These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 9154398

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinico-mycological study of onychomycosis and in vitro antifungal susceptibility of Trichophyton rubrum.
    Huang X, Wang Q, Yan QH, Feng S, Zhang GQ, Yuan XY.
    Eur J Dermatol; 2024 Jun 01; 34(3):260-266. PubMed ID: 39015959
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Causative pathogens in onychomycosis and the possibility of treatment resistance: a review.
    Evans EG.
    J Am Acad Dermatol; 1998 May 01; 38(5 Pt 3):S32-36. PubMed ID: 9594934
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
    Baudraz-Rosselet F, Ruffieux C, Lurati M, Bontems O, Monod M.
    Dermatology; 2010 May 01; 220(2):164-8. PubMed ID: 20110639
    [Abstract] [Full Text] [Related]

  • 32. Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum.
    Azambuja CV, Pimmel LA, Klafke GB, Xavier MO.
    An Bras Dermatol; 2014 May 01; 89(4):581-6. PubMed ID: 25054744
    [Abstract] [Full Text] [Related]

  • 33. Onychomycosis: modern diagnostic and treatment approaches.
    Tchernev G, Penev PK, Nenoff P, Zisova LG, Cardoso JC, Taneva T, Ginter-Hanselmayer G, Ananiev J, Gulubova M, Hristova R, Nocheva D, Guarneri C, Martino G, Kanazawa N.
    Wien Med Wochenschr; 2013 Jan 01; 163(1-2):1-12. PubMed ID: 23053563
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro.
    Nakashima T, Nozawa A, Ito T, Majima T.
    J Infect Chemother; 2002 Dec 01; 8(4):331-5. PubMed ID: 12525893
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of antifungal agents in onychomycoses.
    Debruyne D, Coquerel A.
    Clin Pharmacokinet; 2001 Dec 01; 40(6):441-72. PubMed ID: 11475469
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.